Newport Corporation announced that it has entered into an agreement to acquire FEMTOLASERS Produktions GmbH, a leading developer and manufacturer of ultrafast laser systems used extensively in scientific andbiomedical research applications. Widely recognized for developing the world’s highest precision ultrafast lasers, FEMTOLASERS enables some of the most advanced research applications, including the pioneering of attosecond (10-18 second) science to study physical, chemical and biological phenomena at the atomic and subatomic levels.
“We are excited to announce our agreement to acquire FEMTOLASERS, which will advance our
strategic initiative to extend our industry leadership in ultrafast lasers,” said David Allen, Senior Vice President and General Manager of Newport’s Spectra-Physics Lasers Group.
“FEMTOLASERS has developed some truly impressive leading-edge technology that will be invaluable as we work together to develop the next generation of ultrafast lasers. We welcome the FEMTOLASERS team to Newport and look forward to their contributions to our Spectra-Physics Lasers Group.”
Established in 1994, FEMTOLASERS is headquartered in Vienna, Austria and has an installed base of more than 850 systems in over 30 countries. In the first 12 months after closing, Newport expects FEMTOLASERS’ sales to be in the range of $8 million to $12 million, and expects the transaction to be accretive to its earnings. Terms of the transaction, which is anticipated to close during the first quarter of 2015, were not disclosed.